Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-26T22:54:00.234Z Has data issue: false hasContentIssue false
  • English
  • Français

Actuarial V. Clinical Prediction

Published online by Cambridge University Press:  29 January 2018

N. McConaghy
N. McConaghy*
Affiliation:
University of New South Wales, Prince Henry Hospital, Little Bay, N.S.W. 2036. Australia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 117 , Issue 536 , July 1970 , pp. 122 - 123
Copyright
Copyright © Royal College of Psychiatrists, 1970 

References

Ashby, W. R., and Collins, G. H. (1961). ‘A clinical trial of imipramine (Tofranil) on depressed patients.’ Journal of Mental Science, 107, 547–51.Google Scholar
Hare, E. H., McCance, C., and McCormick, L. (1964). ‘Imipramine and “Drinamyl” in depressive illness. A comparative trial.’ British Medical Journal, i, 818–21.Google Scholar
Lipman, R. S., Cole, J. O., Park, L. D., and Rickels, K. (1965). ‘Sensitivity of symptom and non-symptom focused criteria of out-patient drug efficiency.’ American Journal of Psychiatry, 122, 24–7.Google Scholar
McConaghy, N. (1969). ‘The place of behaviour therapy in the treatment of anxiety.’ Australian and New Zealand Journal of Psychiatry, 3, No. 3a, 293–8.Google Scholar
Overall, J. E., Hollister, L. E., Meyer, F., Kimbell, I. Jr., and Shelton, J. (1964). ‘Imipramine and thioridazine in depressed and schizophrenic patients. Are there specific antidepressant drugs?’ Journal of the American Medical Association, 189, 605–8.Google Scholar
Rickels, K., Raab, E., and Carranza, K. J. (1965). ‘Doctor medication guesses: an indicator of clinical improvement in double-blind studies.’ Journal of New Drugs, 5, 67–71.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.